Abstract
Biotechnology Law ReportVol. 34, No. 5 Legal BriefsAriosa Diagnostics, Inc., and Natera, Inc., Plaintiffs-Appellees, and DNA Diagnostics Center, Inc., Counterclaim Defendant-Appellee, v. Sequenom, Inc., and Sequenom Center for Molecular Medicine, LLC, Defendants-Appellants, and ISIS Innovation Limited, Defendant (United States Court of Appeals for the Federal Circuit)Published Online:21 Oct 2015https://doi.org/10.1089/blr.2015.29012.holAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byFederal Judge Seeks Patent CasesSSRN Electronic JournalRecent Developments in Patent Law 2019SSRN Electronic Journal, Vol. 208Patent Reform, Then and NowSSRN Electronic JournalShould We Change EU Law to Disallow DNA Patents?SSRN Electronic JournalWill Your Veil Be Pierced? How Strong is Your Entityys Liability Shield? Piercing the Veil, Alter Ego, and Other Bases for Holding an Owner Liable for Debts of an EntitySSRN Electronic JournalTorts Compendium, Volume One (Version 1.0)SSRN Electronic Journal Volume 34Issue 5Oct 2015 InformationCopyright 2015, Mary Ann Liebert, Inc.To cite this article:Ariosa Diagnostics, Inc., and Natera, Inc., Plaintiffs-Appellees, and DNA Diagnostics Center, Inc., Counterclaim Defendant-Appellee, v. Sequenom, Inc., and Sequenom Center for Molecular Medicine, LLC, Defendants-Appellants, and ISIS Innovation Limited, Defendant (United States Court of Appeals for the Federal Circuit).Biotechnology Law Report.Oct 2015.171-175.http://doi.org/10.1089/blr.2015.29012.holPublished in Volume: 34 Issue 5: October 21, 2015PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.